Alignment Healthcare ALHC Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $3.91B+46.4% | $2.67B+48.4% | $1.8B+25.8% | $1.43B+22.7% | ||
| $3.95B+46.1% | $2.7B+48.3% | $1.82B+27.2% | $1.43B+22.8% | ||
| $443.41M+19.4% | $371.37M+20.8% | $307.43M+4.0% | $295.65M+1.6% | ||
| $30.4M+13.1% | $26.87M+25.5% | $21.41M+24.0% | $17.27M+9.2% | ||
| $3.93B+40.2% | $2.81B+43.7% | $1.95B+24.9% | $1.56B+16.1% | ||
| $3.93B+40.2% | $2.81B+43.7% | $1.95B+24.9% | $1.56B+16.1% | ||
| —— | -$101.56M+20.5% | -$127.82M+0.6% | -$128.64M+27.8% | ||
| $15.8M-32.9% | $23.55M+10.9% | $21.23M+16.1% | $18.29M+4.9% | ||
| -$15.71M+40.7% | -$26.5M-30.0% | -$20.38M+1.4% | -$20.66M-20.0% | ||
| -$958K+99.3% | -$128.05M+13.6% | -$148.2M+0.7% | -$149.3M+23.5% | ||
| —— | $21K+195% | -$22K-106% | $339K— | ||
| -$724K+99.4% | -$128.04M+13.5% | -$148.02M+1.0% | -$149.55M+23.4% | ||
| -0%+4.7pp | -4.7%+3.4pp | -8.1%+2.3pp | -10.4%+6.3pp | ||
| -$0.01+98.5% | -$0.68+13.9% | -$0.79+4.8% | -$0.83+27.8% | ||
| $0.00+100% | -$0.68+13.9% | -$0.79+4.8% | -$0.83+27.2% | ||
| 810.1M+6.3% | 762.1M+2.6% | 742.6M— | —— | ||
| 789M+3.5% | 762.1M+2.6% | 742.6M— | —— | ||
| $3.46B+43.8% | $2.41B+48.3% | $1.62B+29.8% | $1.25B+20.3% | ||
| $37M+17.0% | $31.63M+39.4% | $22.7M+770% | $2.61M— | ||
| $89K+23.6% | $72K+102% | -$4.17M— | —— | ||
| $14.75M+115% | -$101.56M+20.5% | -$127.82M+0.6% | -$128.64M+27.8% | ||
| $45.16M+160% | -$74.68M+29.8% | -$106.4M+4.5% | -$111.37M+31.4% | ||
| $45.16M+160% | -$74.68M+29.8% | -$106.4M+4.5% | -$111.37M+31.4% | ||
| 1.1%+3.9pp | -2.8%+3.1pp | -5.8%+1.9pp | -7.8%+6.1pp | ||
| $14.75M+115% | -$101.56M+20.5% | -$127.82M+0.6% | -$128.64M+27.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Alignment Healthcare's income statement data come from?
- Every line is extracted from Alignment Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.